Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
After finishing at $0.5 in the prior trading day, Reviva Pharmaceuticals Holdings Inc (NASDAQ: RVPH) closed at $0.48, down -3.82%. In other words, the price has decreased by -$3.82 from its previous closing price. On the day, 3.0 million shares were traded. RVPH stock price reached its highest trading level at $0.5378 during the session, while it also had its lowest trading level at $0.4827.
Ratios:
Our goal is to gain a better understanding of RVPH by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.39 and its Current Ratio is at 1.39. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Chardan Capital Markets on September 29, 2025, initiated with a Buy rating and assigned the stock a target price of $2.
On September 20, 2023, ROTH MKM started tracking the stock assigning a Buy rating and target price of $12. On June 08, 2023, The Benchmark Company started tracking the stock assigning a Speculative Buy rating and target price of $17.The Benchmark Company initiated its Speculative Buy rating on June 08, 2023, with a $17 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RVPH now has a Market Capitalization of 55099972 and an Enterprise Value of 23900946.
Stock Price History:
The Beta on a monthly basis for RVPH is 0.01, which has changed by -0.60317457 over the last 52 weeks, in comparison to a change of 0.1380992 over the same period for the S&P500. Over the past 52 weeks, RVPH has reached a high of $4.28, while it has fallen to a 52-week low of $0.25. The 50-Day Moving Average of the stock is -5.36%, while the 200-Day Moving Average is calculated to be -36.49%.
Shares Statistics:
The stock has traded on average 9.61M shares per day over the past 3-months and 4301710 shares per day over the last 10 days, according to various share statistics. A total of 115.06M shares are outstanding, with a floating share count of 109.16M. Insiders hold about 5.13% of the company’s shares, while institutions hold 11.15% stake in the company. Shares short for RVPH as of 1761868800 were 22384162 with a Short Ratio of 2.33, compared to 1759190400 on 13860222. Therefore, it implies a Short% of Shares Outstanding of 22384162 and a Short% of Float of 20.51.
Earnings Estimates
. The current assessment of Reviva Pharmaceuticals Holdings Inc (RVPH) involves the perspectives of 2.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is -$0.08, with high estimates of -$0.04 and low estimates of -$0.14.
Analysts are recommending an EPS of between -$0.28 and -$0.35 for the fiscal current year, implying an average EPS of -$0.31. EPS for the following year is -$0.29, with 7.0 analysts recommending between $0.0 and -$0.85.
